Jesús Soberino García

Jesús Soberino García

MEDICAL ONCOLOGY SPECIALIST

Key information

  • Atezolizumab in the treatment of metastatic triple-negative breast cancer.

Professional Details

Centro Médico Teknon
SPECIALIST PHYSICIAN MEDICAL ONCOLOGY
July 2023 - Present
Hospital Quirónsalud Barcelona
SPECIALIST PHYSICIAN MEDICAL ONCOLOGY
October 2020 - Present
Hospital El Pilar
SPECIALIST PHYSICIAN MEDICAL ONCOLOGY
September 2022 - Present
Atezolizumab in the treatment of metastatic triple-negative breast cancer.
Journal Article
Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy.
Clinical Trial, Phase II, Journal Article
Pembrolizumab plus eribulin in hormone-receptor-positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase ? trial.
Journal Article
Make an appointment with this professional